October 2026 eligibility centers on implanted patients with device-related injury, not all stimulator users. Federal Boston Scientific cases are centralized in MDL 3181, while no product-liability settlement has been reached for any major maker.
A spinal cord stimulator is an implanted device that sends electrical pulses to the spinal cord to reduce chronic pain. Lawsuits focus on devices from Abbott/St. Jude, Boston Scientific, Medtronic, or Nevro that allegedly caused shocks, loss of therapy, or injury requiring medical care or surgery.
Official resources:
- Read the original report from Govdelivery — Use this primary source to review the complete report.
- Check eligibility on Drugwatch’s official study page — Use this page to check the study’s participation requirements.
Table of Contents
- Who may qualify now
- Where do federal cases stand
- Which devices and failures are involved
- What limits could defeat a claim
- What should you do next
Who may qualify now
Eligible patients are generally those implanted with a stimulator from Abbott/St. Jude, Boston Scientific, Medtronic, or Nevro who later suffered a device-related harm.
The harm must connect to the device, not to the underlying back or nerve condition alone. Relevant problems include: Medical and device records matter because model, implant date, symptoms, and surgical findings help show that link.
- shocks, burns, or painful stimulation
- lead migration or fracture and loss of therapy
- worsening pain, infection, or neurological injury
- revision, replacement, explant, or removal surgery
Where do federal cases stand
Federal Boston Scientific product-liability cases were centralized on June 5, 2026, as MDL 3181 in the Central District of California before Judge Josephine L. Staton. As the Robert King Law Firm update reports, the court denied broader industry-wide consolidation Robert King Law Firm case update. That means Abbott, Medtronic, and Nevro federal cases continue outside MDL 3181.
The Lawsuit Information Center reports that separate petitions for Abbott and Nevro cases were heard Sept. 24, 2026, with no decision posted as of Sept. 29, 2026 federal litigation status page. Patients should therefore identify the maker and model first. The court path can differ by manufacturer.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
Which devices and failures are involved
The U.S. FDA classified Boston Scientific's Infinion CX lead removal as a Class I recall after 1,081 serious injuries and no deaths reported as of May 27, 2026 FDA recall bulletin. The cited problem was anchor-site stress causing high impedance, fractures, inadequate stimulation, and possible explant or replacement.
That removal action covers unused Infinion CX Lead Kits SC-2317-50 and SC-2317-70, which must leave use or sale. Already-implanted leads are expressly not affected by that removal action. A separate earlier recall involved about 155,028 Abbott Proclaim and Infinity pulse generators distributed from 2015–2023 after 73 injuries tied to devices locking in MRI mode and losing therapy, also classified Class I. A reader with an Abbott device should check generator model, implant paperwork, and whether therapy loss followed MRI exposure.
What limits could defeat a claim
A device problem alone does not guarantee compensation. On March 25, 2026, the Ninth Circuit affirmed summary judgment for Medtronic against plaintiff William Hunt, whose stimulator implanted in 2021 malfunctioned and was removed in June 2021. That result underlines proof requirements around defect, causation, medical evidence, and federal or state legal defenses.
Time limits also vary by state and can bar an otherwise serious injury claim. No Boston Scientific, Abbott, Medtronic, or Nevro product-liability settlement had been reached as of fall 2026. Readers should weigh that litigation remains contested and unresolved.
What should you do next
Potentially eligible patients should preserve implant cards, model numbers, and surgical records and check state filing deadlines promptly, according to the TorHoerman Law October 2026 update October 2026 legal update. Those materials help a lawyer identify the maker, confirm the device, and evaluate injury and timing.
Useful records include the implant operative report, device interrogation reports, pain-management notes, imaging, explant or revision records, and receipts for medical costs and lost work. Keep the original documents and avoid discarding an explanted device without legal advice.
You Might Also Like
- Depo Provera Lawsuit Settlement Update: What October 2026 Changed
- Legal Glossary Mass Tort Litigation FAQ for October 2026: Source-Checked Answers to Common Questions
- How to Verify Eligibility Tools Mass Tort Litigation Claims in 2026: court filings and agency notices, Evidence, and Red Flags